Ipsen Biopharm Limited
Manufacture of basic pharmaceutical products · Wrexham
ActiveUnited KingdomIncorporated 1982Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No electronic account filings
No extracted electronic accounts are available in our records.
Registered details
01653765- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 1982-07-23
- Jurisdiction
- —
- Registered office
- ASH ROAD, WREXHAM, LL13 9UF
Classification
1 SIC codes21100
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
3 matched grantsNovel production process for a highly potent recombinant protein using doggybone DNA (dbDNA) vector and cell free expression technologyLeadInnovate UK · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 2 other participants£222,534awarded
Novel production process for a highly potent recombinant protein using doggybone DNA (dbDNA) vector and cell free expression technologyLead
Innovate UK · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 2 other participants
£222,534
awarded
Ipsen Biopharm Limitedlead£222,534
Novel production process for a highly potent recombinant protein using doggybone DNA (dbDNA) vector and cell free expression technologyLeadISCF · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 2 other participants£852,841whole project
Novel production process for a highly potent recombinant protein using doggybone DNA (dbDNA) vector and cell free expression technologyLead
ISCF · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 2 other participants
£852,841
whole project
Novel production process for a highly potent recombinant protein using doggybone DNA (dbDNA) vector and cell free expression technologyISCF · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 2 other participants£852,841whole project
Novel production process for a highly potent recombinant protein using doggybone DNA (dbDNA) vector and cell free expression technology
ISCF · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 2 other participants
£852,841
whole project